BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30822414)

  • 21. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical calcipotriol for preventive treatment of hypertrophic scars: a randomized, double-blind, placebo-controlled trial.
    van der Veer WM; Jacobs XE; Waardenburg IE; Ulrich MM; Niessen FB
    Arch Dermatol; 2009 Nov; 145(11):1269-75. PubMed ID: 19917956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Testing of a Skin Topical Formulation
    Basson R; Baguneid M; Foden P; Al Kredly R; Bayat A
    Adv Wound Care (New Rochelle); 2019 May; 8(5):208-219. PubMed ID: 31737415
    [No Abstract]   [Full Text] [Related]  

  • 24. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
    Noh SU; Cho EA; Kim HO; Park YM
    Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women.
    Most J; Penders J; Lucchesi M; Goossens GH; Blaak EE
    Eur J Clin Nutr; 2017 Sep; 71(9):1040-1045. PubMed ID: 28589947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigallocatechin-3-gallate attenuates acute and chronic psoriatic itch in mice: Involvement of antioxidant, anti-inflammatory effects and suppression of ERK and Akt signaling pathways.
    Guo R; Zhou FM; Su CJ; Liu TT; Zhou Y; Fan L; Wang ZH; Liu X; Huang Y; Liu T; Yang J; Chen LH
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1062-1068. PubMed ID: 29402411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial.
    Nguyen JK; Weedon J; Jakus J; Heilman E; Isseroff RR; Siegel DM; Jagdeo JR
    Trials; 2019 Jul; 20(1):432. PubMed ID: 31307501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
    Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
    J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease.
    Widlansky ME; Hamburg NM; Anter E; Holbrook M; Kahn DF; Elliott JG; Keaney JF; Vita JA
    J Am Coll Nutr; 2007 Apr; 26(2):95-102. PubMed ID: 17536120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary epigallocatechin 3-gallate supplement improves maternal and neonatal treatment outcome of gestational diabetes mellitus: a double-blind randomised controlled trial.
    Zhang H; Su S; Yu X; Li Y
    J Hum Nutr Diet; 2017 Dec; 30(6):753-758. PubMed ID: 28266082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
    Gee JR; Saltzstein DR; Kim K; Kolesar J; Huang W; Havighurst TC; Wollmer BW; Stublaski J; Downs T; Mukhtar H; House MG; Parnes HL; Bailey HH
    Cancer Prev Res (Phila); 2017 May; 10(5):298-307. PubMed ID: 28325826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.
    Ullmann U; Haller J; Decourt JD; Girault J; Spitzer V; Weber P
    Int J Vitam Nutr Res; 2004 Jul; 74(4):269-78. PubMed ID: 15580809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing skin penetration of epigallocatechin gallate by modifying partition coefficient using reverse micelle method.
    Rosita N; Meitasari VA; Rianti MC; Hariyadi DM; Miatmoko A
    Ther Deliv; 2019 Jul; 10(7):409-417. PubMed ID: 31319784
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies.
    Kircik LH
    J Drugs Dermatol; 2013 Jan; 12(1):86-90. PubMed ID: 23377333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations.
    Scalia S; Trotta V; Bianchi A
    Acta Pharm; 2014 Jun; 64(2):257-65. PubMed ID: 24914725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy-induced severe pre-eclampsia: A double-blind, randomized and placebo-controlled clinical study.
    Shi DD; Guo JJ; Zhou L; Wang N
    J Clin Pharm Ther; 2018 Feb; 43(1):21-25. PubMed ID: 28726273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.
    Dvorakova K; Dorr RT; Valcic S; Timmermann B; Alberts DS
    Cancer Chemother Pharmacol; 1999; 43(4):331-5. PubMed ID: 10071985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.
    Rust R; Chien C; Scheel M; Brandt AU; Dörr J; Wuerfel J; Klumbies K; Zimmermann H; Lorenz M; Wernecke KD; Bellmann-Strobl J; Paul F
    Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33622766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of the immediate and long-term effect of massage on adult postburn scar.
    Nedelec B; Couture MA; Calva V; Poulin C; Chouinard A; Shashoua D; Gauthier N; Correa JA; de Oliveira A; Mazer B; LaSalle L
    Burns; 2019 Feb; 45(1):128-139. PubMed ID: 30626496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute neurocognitive effects of epigallocatechin gallate (EGCG).
    Scholey A; Downey LA; Ciorciari J; Pipingas A; Nolidin K; Finn M; Wines M; Catchlove S; Terrens A; Barlow E; Gordon L; Stough C
    Appetite; 2012 Apr; 58(2):767-70. PubMed ID: 22127270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.